Patents Assigned to Sloan-Kettering Instutute for Cancer Research
  • Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
    Patent number: 5102663
    Abstract: The present invention provides a vaccine for stimulating or enhancing in a subject to whom the vaccine is administered, production of antibodies directed against 9-O-acetyl GD3 ganglioside comprising an amount of purified 9-O-acetyl GD3 ganglioside effective to stimulate or enhance antibody productionThis invention was made with government support under Grant Numbers CA-40532 and CA-43971, National Cancer Institute, Department of Health and Human Services. Accordingly, the U.S. Government has certain rights in the invention.
    Type: Grant
    Filed: October 18, 1988
    Date of Patent: April 7, 1992
    Assignee: Sloan-Kettering Instutute for Cancer Research
    Inventors: Philip O. Livingston, Gerd J. Ritter, Herbert F. Oettgen, Lloyd J. Old